How Meta's AI system for emotion and health analysis works

Meta has received a patent for an AI system that uses computer vision and biometric sensors to track user emotions and manage medication intake, offering recommendations based on mood and behavioral analysis.

How the device works

According to the patent description, the device continuously records the user's environment (camera and microphone) and uses computer vision and biometric sensors to recognize emotional state. The system analyzes facial expressions, voice tone, heart rate, and other markers of mental state, then makes suggestions: from reminding to take medication to recommendations like "you seem upset right now, maybe take a walk?" The device collects and combines multiple types of data about the user—from video content to biometric data—to build a model of their mental and physical state.

• Continuous video recording of the user's environment
• Emotion analysis through facial recognition, voice tone, and biometric data
• Medication intake monitoring (via camera or built-in sensors)
• Personalized recommendations based on current state
• Integration with medical history and treatment schedule

Healthcare applications

Such a device could potentially improve the lives of millions of people with chronic diseases, depression, and anxiety. The key goal is to improve patient adherence to treatment regimens: research shows that up to 50% of patients miss medication doses, either forgetting or out of inertia. An AI assistant can remind at critical moments when motivation wanes, or even recognize when a patient is "forgetting" deliberately—and suggest a conversation with a doctor about side effects.

Additionally, real-time emotion monitoring provides doctors with invaluable data about a patient's mental state between visits—information that today doctors receive only from subjective patient questionnaires or patient descriptions. For people with depression, bipolar disorder, or trauma, this could mean more accurate diagnosis and treatment.

Privacy and control concerns

But the patent immediately raised sharp questions from critics and regulators: a device that constantly watches, listens, and analyzes could become a tool of total control. What data is stored in Meta's cloud? How does the company encrypt and protect it? Could AI recommendations evolve over time into manipulation—for example, "you're sad, maybe buy something?" followed by targeted advertising aligned with your emotional profile?

Big Tech history shows: health and mental data are the most sensitive and potentially profitable. A company that knows your weakness in real time can monetize it inappropriately. Furthermore, questions remain: did the patient give informed consent to constant video surveillance, or is this a condition the company dictates?

It remains unclear whether such a device will ever be released to market. Many ambitious Meta patents remain conceptual and never reach consumers.

What does this mean

Large tech companies are increasingly entering the healthcare and biomonitoring segment, blurring the line between helpfulness and invasiveness. If such devices appear, questions about privacy, consent, and data collection must be resolved before launch, otherwise the risk of transforming healthcare into a tool of total surveillance is too great. Regulators need clear rules—and they should be adopted now, before the device appears.

*Meta has been recognized as an extremist organization and is banned in the Russian Federation.

How does the AI system recognize emotions?

The system analyzes facial expressions, voice tone, heart rate, and other mental state markers through computer vision and biometric sensors.

When will it be possible to use this system?

Right now this is just a Meta patent. Product implementation plans have not been announced.